Evaluation of the thermal stability and the protective efficacy of spray-dried HPV vaccine, Gardasil® 9
High-risk human papillomavirus (HPV) types are responsible for nearly all cases of cervical cancers. Cervarix® and Gardasil® 9 are the current prophylactic vaccines available that protect against the majority of HPVs associated with cancer. Although these vaccines are highly effective, HPV vaccine i...
Saved in:
Main Authors: | Nitesh K. Kunda (Author), Julianne Peabody (Author), Lukai Zhai (Author), Dominique N. Price (Author), Bryce Chackerian (Author), Ebenezer Tumban (Author), Pavan Muttil (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2019-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RNA Phage VLP-Based Vaccine Platforms
by: David S. Peabody, et al.
Published: (2021) -
GARDASIL. QUADRIVALENT RECOMBINANT VACCINE AGAINST HPV (6, 11, 16, 18 TYPES)
by: article editorial
Published: (2007) -
GARDASIL. QUADRIVALENT RECOMBINANT VACCINE AGAINST HPV (6, 11, 16, 18 TYPES)
by: article editorial
Published: (2007) -
Reactogenicity of Cervarix and Gardasil human papillomavirus (HPV) vaccines in a randomized single blind trial in healthy UK adolescent females
by: Tao Haskins-Coulter, et al.
Published: (2017) -
Advances in Thermal Spray Technology
Published: (2020)